Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Allison R. Hanaford(Johns Hopkins Medicine), Eric H. Raabe(Johns Hopkins University)
Cited by 74
Related Papers
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
|Oncotarget|2014|85
LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program
|Oncotarget|2013|73
Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity
|Neuro-Oncology|2019|36
Peripheral macrophages drive <scp>CNS</scp> disease in the <i>Ndufs4</i>(−/−) model of Leigh syndrome
|Brain Pathology|2023|23
Interferon‐gamma contributes to disease progression in the <i>Ndufs4</i> (−/−) model of Leigh syndrome
|Neuropathology and Applied Neurobiology|2024|14